Compound class:
Synthetic organic
Comment: EAI045 is an allosteric inhibitor of mutant forms of the EGFR found in lung cancers whilst sparing the wild-type receptor [1]. Allosteric inhibitors are being developed to overcome acquired resistance to current EGFR tyrosine kinase inhibitors which bind to the ATP pocket of the enzyme, which is the location of the many identified resistance mutations.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamide |
Database Links ![]() |
|
GtoPdb PubChem SID | 315661298 |
PubChem CID | 121231412 |
Search Google for chemical match using the InChIKey | YTUFHOKUFOQRDF-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | YTUFHOKUFOQRDF |
UniChem Compound Search for chemical match using the InChIKey | YTUFHOKUFOQRDF-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YTUFHOKUFOQRDF-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
EAI045 (links to external site)
Cat. No. HY-100213 |